Humanigen Inc (fka HGENQ)

[$5.95akadawson-m]

I'm a CYDY guy with some shares of HGEN; however, here is why CYDY offers a much bigger payday. This was written minutes ago by Misui, one of the physicians on the CYDY board. I have abridged the post just to make the fine points stand out.

Cowtown Jay,- Leronlimab is the only drug with mortality as a primary endpoint now , as you know Lenzilumab removed mortality and now has length of hospitalization , like all other drugs ...

...we have double blinded study, but blood tests results...of every patient are not a secret during the study,

...from these results our management know how we are doing, this is why they don't change our primary endpoint...and this is why DSMC didn't change our protocol after 50% during interim..

the young lady who did video after participating in our M/M study...said "nurse came day or two after my injection and told me I must be on drug since ALL my blood tests are much better "

All IMO.

CYDY's stock price right now is 70% less, right now, than HGEN. Who do you think is the better buy?